P-253: Impact of adjusting bortezomib dose in the pomalidomide, bortezomib, and dexamethasone (PVd) combination: a post hoc analysis of the OPTIMISMM study — Alessandra Larocca (2022) | RDL Network
P-253: Impact of adjusting bortezomib dose in the pomalidomide, bortezomib, and dexamethasone (PVd) combination: a post hoc analysis of the OPTIMISMM study
Albert Oriol, Meletios A Dimopoulos, Fredrik Schjesvold, Meral Beksaç, Thierry Façon, Sujith Dhanasiri, Shien Guo, Yutian Mu, Kevin Hong, Christian Gentili, Mónica Galli, Münci Yağcı, Alessandra Larocca, Paul G. Richardson, Katja Weisel
Fredrik Schjesvold, Meletios A Dimopoulos, Meral Beksaç, Albert Oriol, Jindriska Lindsay, Anna Marina Liberati, Mónica Galli, Paweł Robak, Katja Weisel, Alessandra Larocca, Münci Yağcı, Filiz Vural, Larry Anderson, Abraham S. Kanate, Eva Casal Mendez, Ruiyun Jiang, Shankar Srinivasan, Lara Grote, Tsvetan Biyukov, Paul G. Richardson
Albert Oriol Rocafiguera, Meletios A Dimopoulos, Fredrik Schjesvold, Meral Beksaç, Münci Yağcı, Alessandra Larocca, Shien Guo, Yutian Mu, Kevin Hong, Sujith Dhanasiri, Paul G. Richardson, Katja Weisel
Albert Oriol, Meletios A Dimopoulos, Fredrik Schjesvold, M. Beksac, Münci Yağcı, Alessandra Larocca, S. Guo, Y. Mu, Kevin Hong, Sujith Dhanasiri, PG Richardson, Katja Weisel
Meletios A Dimopoulos, Katja Weisel, Philippe Moreau, Larry D. Anderson, Darrell White, Jesús F. San Miguel, Pieter Sonneveld, Monika Engelhardt, Matthew Jenner, Alessandro Corso, Jan Dürig, Michel Pavic, Morten Salomo, Eva Casalz, Ruiyun Jiang, Shankar Srinivasan, Tuong Vi Nguyen, Amine Bensmaine, Teresa Peluso, Paul G. Richardson
Discussion(0)
No comments yet. Be the first to comment.